Article
Testing for Inherited Susceptibility to Breast Cancer.
Hematology/oncology clinics of North America - 1 Feb 2023
Robson Mark
Abstract excerpt
When BRCA1 and BRCA2 were first identified, the initial models for delivering testing were shaped by concepts of genetic exceptionalism and a lack of data regarding therapeutic implications and the effectiveness of risk reduction. Since then, interventions have been effective, and treatment implications have become clear. The sensitivity of guideline-based testing is incomplete, leading to calls for universal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
